Biohit Healthcare

Helsinki, Finland Founded: 1988 • Age: 38 yrs Listed
Diagnostics products and servcies

About Biohit Healthcare

Biohit Healthcare is a publicly listed company based in Helsinki (Finland) founded in 1988. Diagnostics products and servcies. Biohit Healthcare offers products and services including FAEX Sample System. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics. Its legal entity is Biohit Oyj.

Company details

Biohit Healthcare provides diagnostic products and services. Its flagship product Gastropanel is a rapid assay that detects the presence of H. pylori and atrophic gastritis from a blood sample. The company also develops and markets acetyldehyde-binding products, monoclonal antibodies and instrumentation to support automation of their ELISA tests.

Key Metrics
  • Annual Revenue
    $18.48 M (USD)
    10.14
    as on Dec 31, 2025
  • Net Profit
    $3.22 M (USD)
    6.62
    as on Dec 31, 2025
  • EBITDA
    $4 M (USD)
    20.72
    as on Dec 31, 2025

Products & Services of Biohit Healthcare

Biohit Healthcare offers a comprehensive portfolio of products and services, including FAEX Sample System.

FAEX Sample System
Diagnostic Tools

System for collecting and handling medical samples for diagnostics.

IPO & Listings of Biohit Healthcare

Biohit Healthcare is a publicly listed company on the OMXHEX with ticker symbol BIOBV in Finland, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date27 Oct 2007
  • Listed onLSE: 0DRP
  • Listed entityBiohit Oyj Class B
  • Exchange sectorHealth technology
  • ISINFI0009005482
  • Share price2.27 EUR (-1.3% on the day) · 2026-10-14
  • Market capitalisation34,972,863.00 EUR
  • Price to earnings11.4
  • EPS (diluted, trailing year)0.20 EUR
  • Volume (last session)9,858

Financials of Biohit Healthcare

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
202515.7M EUR2.7M EUR3.4M EUR
202414.3M EUR2.6M EUR2.8M EUR
202313.1M EUR1.9M EUR2.2M EUR
202210.9M EUR601,000 EUR1.7M EUR
20219.4M EUR-1.5M EUR402,000 EUR
Premium access

Detailed financial statements for Biohit Healthcare

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Web traffic of Biohit Healthcare

The website of Biohit Healthcare (biohithealthcare.com) receives about 3.4K visits a month.

  • Monthly visits
    3.4K

    ▼ 13.1% vs previous month

Similar websites

Websites whose visitors overlap most with Biohit Healthcare. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
mylabsforlife.com
100%
#4,982,465View details
walkinlab.com
89%
174.3K#207,324View details
biohit.com
biohit.com
83%
–
melonbio.ru
melonbio.ru
68%
#7,484,807–
express-test.okis.ru
express-test.okis.ru
68%
–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 22 similar websites and full traffic analytics for Biohit Healthcare

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 22 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Biohit Healthcare

Premium access

Complete news archive for Biohit Healthcare

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Biohit Healthcare

Biohit Healthcare was founded in 1988.

Biohit Healthcare is headquartered in Helsinki, Finland.

Annual revenue of Biohit Healthcare is $18.48M as on Dec 31, 2025.

Biohit Healthcare provides diagnostic products and services. Its flagship product Gastropanel is a rapid assay that detects the presence of H. pylori and atrophic gastritis from a blood sample. The company also develops and markets acetyldehyde-binding products, monoclonal antibodies and instrumentation to support automation of their ELISA tests.

Biohit Healthcare offers FAEX Sample System.

Yes, Biohit Healthcare is publicly traded on OMXHEX under the ticker symbol BIOBV.

Biohit Healthcare operates through Biohit Oyj.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available